Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Weizman

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 3, 2007
DHEAS repeated treatment improves cognitive and behavioral deficits after mild traumatic brain injuryA Milman, O Zohar, R Maayan, et al.
Journal of Child and Adolescent Psychopharmacology|July 28, 2009
"Peripheral" benzodiazepine receptor density is not altered by methylphenidate treatment in children with attention-deficit hyperactivity disorderR Weizman, D E Dar, S Landa, et al.
Pharmacology, Biochemistry, and Behavior|September 24, 1999
The atypical neuroleptics clozapine and olanzapine differ regarding their antinociceptive mechanisms and potencyS Schreiber, V Getslev, M M Backer, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|February 1, 1996
State and trait anxiety in adolescent suicide attemptersR Ohring, A Apter, G Ratzoni, et al.
Biological Psychiatry|January 1, 1994
Cytokine production in major depressed patients before and after clomipramine treatmentR Weizman, N Laor, E Podliszewski, et al.
Psychiatric Genetics|April 28, 2001
A rare short allele of the serotonin transporter promoter region (5-HTTLPR) found in an aggressive schizophrenic patient of Jewish Libyan originA Frisch, B Finkel, E Michaelovsky, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 1, 1995
Case study: emergence of transient compulsive symptoms during treatment with clothiapineP Toren, E Samuel, R Weizman, et al.
Neuropsychobiology|January 1, 1987
Lack of effect of 28 days of neuroleptic treatment on platelet benzodiazepine binding sites in schizophrenicsZ Tanne, R Weizman, L Karp, et al.
International Journal of Immunopharmacology|May 1, 1997
Peripheral-type benzodiazepine receptor ligands modulate human natural killer cell activityH Bessler, B Caspi, M Gavish, et al.
The Journal of Nervous and Mental Disease|December 1, 1999
Image control and symptom expression in posttraumatic stress disorderN Laor, L Wolmer, Z Wiener, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 3, 2007
DHEAS repeated treatment improves cognitive and behavioral deficits after mild traumatic brain injuryA Milman, O Zohar, R Maayan, et al.
Journal of Child and Adolescent Psychopharmacology|July 28, 2009
"Peripheral" benzodiazepine receptor density is not altered by methylphenidate treatment in children with attention-deficit hyperactivity disorderR Weizman, D E Dar, S Landa, et al.
Pharmacology, Biochemistry, and Behavior|September 24, 1999
The atypical neuroleptics clozapine and olanzapine differ regarding their antinociceptive mechanisms and potencyS Schreiber, V Getslev, M M Backer, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|February 1, 1996
State and trait anxiety in adolescent suicide attemptersR Ohring, A Apter, G Ratzoni, et al.
Biological Psychiatry|January 1, 1994
Cytokine production in major depressed patients before and after clomipramine treatmentR Weizman, N Laor, E Podliszewski, et al.
Psychiatric Genetics|April 28, 2001
A rare short allele of the serotonin transporter promoter region (5-HTTLPR) found in an aggressive schizophrenic patient of Jewish Libyan originA Frisch, B Finkel, E Michaelovsky, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 1, 1995
Case study: emergence of transient compulsive symptoms during treatment with clothiapineP Toren, E Samuel, R Weizman, et al.
Neuropsychobiology|January 1, 1987
Lack of effect of 28 days of neuroleptic treatment on platelet benzodiazepine binding sites in schizophrenicsZ Tanne, R Weizman, L Karp, et al.
International Journal of Immunopharmacology|May 1, 1997
Peripheral-type benzodiazepine receptor ligands modulate human natural killer cell activityH Bessler, B Caspi, M Gavish, et al.
The Journal of Nervous and Mental Disease|December 1, 1999
Image control and symptom expression in posttraumatic stress disorderN Laor, L Wolmer, Z Wiener, et al.
Pageof 13